A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Clinical trial NCT02137681 · WITHDRAWN

Trial details

NCT number: NCT02137681
Sponsor: Shandong University
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2014-05-01
Primary completion: 2015-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.